ClinicalTrials.Veeva

Menu

The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Post Burn Scars

V

Vall d'Hebron University Hospital (HUVH)

Status

Completed

Conditions

Cicatrix, Hypertrophic

Treatments

Device: Extracorporal Shock Wave Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04558944
PR(ATR)398/2016

Details and patient eligibility

About

A prospective, randomized, controlled study. The patients were divided into two groups with twenty patients per group. The control group received the standard treatment for postburn scars. The treatment group received the standard treatment and treatment of postburn scars with Extracorporeal Shock Wave Therapy 512 impulses of 0.15mJ/mm 2 in each session, twice per week for 4 weeks.

The investigators assessed the appearance of scar with the Vancouver Scar Scale (VSS), pruritus and pain with Visual Analog Scale (VAS) before the start of the treatment and at 2 weeks and 5 months after the treatment.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with hypertrophic post burn scars of approximately 64 cm2 surface area.

Exclusion criteria

  • Patients younger than 18 year.
  • Pregnant women.
  • Having a known skin condition (e.g. psoriasis, skin cancer etc.).
  • Immunosuppression.
  • Hemophilia .
  • Matured scars.
  • Scars located above the lungs, the bowels, the gonads or electronic implants.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control group
No Intervention group
Description:
This group received pain and pruritus medication as needed, received the usual physical therapy as per the protocol of our burn unit, as well as compression garments, silicone sheets and gels and moisturizing cream twice a day. Additionally, the patients were advice on reducing sun exposure and applying +50SPF sunblock on a daily basis.
Extracorporeal Shock Wave Therapy group
Experimental group
Description:
This group received the same treatment as the control group plus Extracorporeal Shock Wave Therapy (The DermaPACE® System, SANUWAVE Health Inc., USA) with Energy Flux Density of 0.15mJ/mm 2 and 512 pulses per session. A total of two sessions per week during a 4-week period.
Treatment:
Device: Extracorporal Shock Wave Therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems